84186-29-8Relevant academic research and scientific papers
C-FMS KINASE INHIBITORS
-
Page/Page column 37-38, (2008/06/13)
The invention is directed to compounds of Formula II: wherein A, R1, R2, R3, R4, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.
C-FMS KINASE INHIBITORS
-
Page 29, (2008/06/13)
The invention is directed to compounds of formulae (I), (II) and (III), wherein A, R1, R2, R3, R4, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein t
SUBSTITUTION OF NITRO GROUPS IN 2,3-DINITROTOLUENE
Piotrovskii, L.B.,Poznyakova, L.N.
, p. 1691 - 1695 (2007/10/02)
The reaction of 2,3-dinitrotoluene with piperidine gives a mixture of 2-piperidino-3-nitrotoluene and 3-piperidino-2-nitrotoluene in a ratio of 3:7.
